On the recordMarch 29, 2023
I am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Source
congress.govI am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Expresses concern over the impact of reduced meetings on FDA's effectiveness.
Share
More from Susan Collins
I am pleased that these funds are being released to help Mainers afford to heat their homes this winter without having to choose between staying warm and paying for other basic necessities.